CDH2 and gastric cancer: CM-DOP inhibited migration by reducing the expression of N-cadherin and vimentin, increasing E-cadherin, and promoting apoptosis through upregulating Caspase-3 and increasing the ratio of Bax/Bcl-2 on gastric cancer cells.